 | • レポートコード：GIR-107A14948 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、凝固因子XIのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。凝固因子XIの種類別市場規模（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）、用途別市場規模（血栓症、出血・凝固障害、急性虚血性脳卒中、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・凝固因子XIの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer AG、Bristol-Myers Squibb Company、Cambryn Biologics LLC、eXithera Pharmaceuticals, Inc、Ionis Pharmaceuticals, Inc.、LegoChem Biosciences, Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他 ・用途別分析2016年-2026年：血栓症、出血・凝固障害、急性虚血性脳卒中、その他 ・凝固因子XIの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・凝固因子XIのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・凝固因子XIのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・凝固因子XIの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・凝固因子XIの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Coagulation Factor XI market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Coagulation Factor XI size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Coagulation Factor XI market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Coagulation Factor XI market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Market segment by Application, can be divided into
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
Market segment by players, this report covers
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Coagulation Factor XI product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Coagulation Factor XI, with revenue, gross margin and global market share of Coagulation Factor XI from 2019 to 2021.
Chapter 3, the Coagulation Factor XI competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Coagulation Factor XI market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Coagulation Factor XI research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Coagulation Factor XI
1.2 Classification of Coagulation Factor XI by Type
1.2.1 Overview: Global Coagulation Factor XI Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Coagulation Factor XI Revenue Market Share by Type in 2020
1.2.3 MR-1007
1.2.4 IONIS-FXIRx
1.2.5 EP-7041
1.2.6 AB-022
1.2.7 BMS-262084
1.2.8 Others
1.3 Global Coagulation Factor XI Market by Application
1.3.1 Overview: Global Coagulation Factor XI Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Thrombosis
1.3.3 Bleeding and Clotting Disorders
1.3.4 Acute Ischemic Stroke
1.3.5 Others
1.4 Global Coagulation Factor XI Market Size & Forecast
1.5 Global Coagulation Factor XI Market Size and Forecast by Region
1.5.1 Global Coagulation Factor XI Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Coagulation Factor XI Market Size by Region, (2016-2021)
1.5.3 North America Coagulation Factor XI Market Size and Prospect (2016-2026)
1.5.4 Europe Coagulation Factor XI Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Coagulation Factor XI Market Size and Prospect (2016-2026)
1.5.6 South America Coagulation Factor XI Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Coagulation Factor XI Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Coagulation Factor XI Market Drivers
1.6.2 Coagulation Factor XI Market Restraints
1.6.3 Coagulation Factor XI Trends Analysis
2 Company Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Coagulation Factor XI Product and Solutions
2.1.4 Bayer AG Coagulation Factor XI Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer AG Recent Developments and Future Plans
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Product and Solutions
2.2.4 Bristol-Myers Squibb Company Coagulation Factor XI Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.3 Cambryn Biologics LLC
2.3.1 Cambryn Biologics LLC Details
2.3.2 Cambryn Biologics LLC Major Business
2.3.3 Cambryn Biologics LLC Coagulation Factor XI Product and Solutions
2.3.4 Cambryn Biologics LLC Coagulation Factor XI Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Cambryn Biologics LLC Recent Developments and Future Plans
2.4 eXithera Pharmaceuticals, Inc
2.4.1 eXithera Pharmaceuticals, Inc Details
2.4.2 eXithera Pharmaceuticals, Inc Major Business
2.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Product and Solutions
2.4.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 eXithera Pharmaceuticals, Inc Recent Developments and Future Plans
2.5 Ionis Pharmaceuticals, Inc.
2.5.1 Ionis Pharmaceuticals, Inc. Details
2.5.2 Ionis Pharmaceuticals, Inc. Major Business
2.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product and Solutions
2.5.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Ionis Pharmaceuticals, Inc. Recent Developments and Future Plans
2.6 LegoChem Biosciences, Inc
2.6.1 LegoChem Biosciences, Inc Details
2.6.2 LegoChem Biosciences, Inc Major Business
2.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Product and Solutions
2.6.4 LegoChem Biosciences, Inc Coagulation Factor XI Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 LegoChem Biosciences, Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Coagulation Factor XI Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Coagulation Factor XI Players Market Share
3.2.2 Top 10 Coagulation Factor XI Players Market Share
3.2.3 Market Competition Trend
3.3 Coagulation Factor XI Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Coagulation Factor XI Revenue and Market Share by Type (2016-2021)
4.2 Global Coagulation Factor XI Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Coagulation Factor XI Revenue Market Share by Application (2016-2021)
5.2 Coagulation Factor XI Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Coagulation Factor XI Revenue by Type (2016-2026)
6.2 North America Coagulation Factor XI Revenue by Application (2016-2026)
6.3 North America Coagulation Factor XI Market Size by Country
6.3.1 North America Coagulation Factor XI Revenue by Country (2016-2026)
6.3.2 United States Coagulation Factor XI Market Size and Forecast (2016-2026)
6.3.3 Canada Coagulation Factor XI Market Size and Forecast (2016-2026)
6.3.4 Mexico Coagulation Factor XI Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Coagulation Factor XI Revenue by Type (2016-2026)
7.2 Europe Coagulation Factor XI Revenue by Application (2016-2026)
7.3 Europe Coagulation Factor XI Market Size by Country
7.3.1 Europe Coagulation Factor XI Revenue by Country (2016-2026)
7.3.2 Germany Coagulation Factor XI Market Size and Forecast (2016-2026)
7.3.3 France Coagulation Factor XI Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Coagulation Factor XI Market Size and Forecast (2016-2026)
7.3.5 Russia Coagulation Factor XI Market Size and Forecast (2016-2026)
7.3.6 Italy Coagulation Factor XI Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Coagulation Factor XI Revenue by Type (2016-2026)
8.2 Asia-Pacific Coagulation Factor XI Revenue by Application (2016-2026)
8.3 Asia-Pacific Coagulation Factor XI Market Size by Region
8.3.1 Asia-Pacific Coagulation Factor XI Revenue by Region (2016-2026)
8.3.2 China Coagulation Factor XI Market Size and Forecast (2016-2026)
8.3.3 Japan Coagulation Factor XI Market Size and Forecast (2016-2026)
8.3.4 South Korea Coagulation Factor XI Market Size and Forecast (2016-2026)
8.3.5 India Coagulation Factor XI Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Coagulation Factor XI Market Size and Forecast (2016-2026)
8.3.7 Australia Coagulation Factor XI Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Coagulation Factor XI Revenue by Type (2016-2026)
9.2 South America Coagulation Factor XI Revenue by Application (2016-2026)
9.3 South America Coagulation Factor XI Market Size by Country
9.3.1 South America Coagulation Factor XI Revenue by Country (2016-2026)
9.3.2 Brazil Coagulation Factor XI Market Size and Forecast (2016-2026)
9.3.3 Argentina Coagulation Factor XI Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Coagulation Factor XI Revenue by Type (2016-2026)
10.2 Middle East & Africa Coagulation Factor XI Revenue by Application (2016-2026)
10.3 Middle East & Africa Coagulation Factor XI Market Size by Country
10.3.1 Middle East & Africa Coagulation Factor XI Revenue by Country (2016-2026)
10.3.2 Turkey Coagulation Factor XI Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Coagulation Factor XI Market Size and Forecast (2016-2026)
10.3.4 UAE Coagulation Factor XI Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Coagulation Factor XI Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Coagulation Factor XI Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Coagulation Factor XI Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Coagulation Factor XI Revenue (USD Million) by Region (2016-2021)
Table 5. Global Coagulation Factor XI Revenue Market Share by Region (2021-2026)
Table 6. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 7. Bayer AG Major Business
Table 8. Bayer AG Coagulation Factor XI Product and Solutions
Table 9. Bayer AG Coagulation Factor XI Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 11. Bristol-Myers Squibb Company Major Business
Table 12. Bristol-Myers Squibb Company Coagulation Factor XI Product and Solutions
Table 13. Bristol-Myers Squibb Company Coagulation Factor XI Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Cambryn Biologics LLC Corporate Information, Head Office, and Major Competitors
Table 15. Cambryn Biologics LLC Major Business
Table 16. Cambryn Biologics LLC Coagulation Factor XI Product and Solutions
Table 17. Cambryn Biologics LLC Coagulation Factor XI Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. eXithera Pharmaceuticals, Inc Corporate Information, Head Office, and Major Competitors
Table 19. eXithera Pharmaceuticals, Inc Major Business
Table 20. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product and Solutions
Table 21. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Ionis Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Ionis Pharmaceuticals, Inc. Major Business
Table 24. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product and Solutions
Table 25. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. LegoChem Biosciences, Inc Corporate Information, Head Office, and Major Competitors
Table 27. LegoChem Biosciences, Inc Major Business
Table 28. LegoChem Biosciences, Inc Coagulation Factor XI Product and Solutions
Table 29. LegoChem Biosciences, Inc Coagulation Factor XI Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Coagulation Factor XI Revenue (USD Million) by Players (2019-2021)
Table 31. Global Coagulation Factor XI Revenue Share by Players (2019-2021)
Table 32. Breakdown of Coagulation Factor XI by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Coagulation Factor XI Players Head Office, Products and Services Provided
Table 34. Coagulation Factor XI Mergers & Acquisitions in the Past Five Years
Table 35. Coagulation Factor XI New Entrants and Expansion Plans
Table 36. Global Coagulation Factor XI Revenue (USD Million) by Type (2016-2021)
Table 37. Global Coagulation Factor XI Revenue Share by Type (2016-2021)
Table 38. Global Coagulation Factor XI Revenue Forecast by Type (2021-2026)
Table 39. Global Coagulation Factor XI Revenue by Application (2016-2021)
Table 40. Global Coagulation Factor XI Revenue Forecast by Application (2021-2026)
Table 41. North America Coagulation Factor XI Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Coagulation Factor XI Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Coagulation Factor XI Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Coagulation Factor XI Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Coagulation Factor XI Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Coagulation Factor XI Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Coagulation Factor XI Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Coagulation Factor XI Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Coagulation Factor XI Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Coagulation Factor XI Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Coagulation Factor XI Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Coagulation Factor XI Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Coagulation Factor XI Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Coagulation Factor XI Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Coagulation Factor XI Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Coagulation Factor XI Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Coagulation Factor XI Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Coagulation Factor XI Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Coagulation Factor XI Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Coagulation Factor XI Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Coagulation Factor XI Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Coagulation Factor XI Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Coagulation Factor XI Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Coagulation Factor XI Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Coagulation Factor XI Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Coagulation Factor XI Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Coagulation Factor XI Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Coagulation Factor XI Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Coagulation Factor XI Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Coagulation Factor XI Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Coagulation Factor XI Picture
Figure 2. Global Coagulation Factor XI Revenue Market Share by Type in 2020
Figure 3. MR-1007
Figure 4. IONIS-FXIRx
Figure 5. EP-7041
Figure 6. AB-022
Figure 7. BMS-262084
Figure 8. Others
Figure 9. Coagulation Factor XI Revenue Market Share by Application in 2020
Figure 10. Thrombosis Picture
Figure 11. Bleeding and Clotting Disorders Picture
Figure 12. Acute Ischemic Stroke Picture
Figure 13. Others Picture
Figure 14. Global Coagulation Factor XI Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Coagulation Factor XI Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Coagulation Factor XI Revenue Market Share by Region (2016-2026)
Figure 17. Global Coagulation Factor XI Revenue Market Share by Region in 2020
Figure 18. North America Coagulation Factor XI Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Coagulation Factor XI Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Coagulation Factor XI Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Coagulation Factor XI Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Coagulation Factor XI Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Coagulation Factor XI Market Drivers
Figure 24. Coagulation Factor XI Market Restraints
Figure 25. Coagulation Factor XI Market Trends
Figure 26. Bayer AG Recent Developments and Future Plans
Figure 27. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 28. Cambryn Biologics LLC Recent Developments and Future Plans
Figure 29. eXithera Pharmaceuticals, Inc Recent Developments and Future Plans
Figure 30. Ionis Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 31. LegoChem Biosciences, Inc Recent Developments and Future Plans
Figure 32. Global Coagulation Factor XI Revenue Share by Players in 2020
Figure 33. Coagulation Factor XI Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Coagulation Factor XI Revenue Market Share in 2020
Figure 35. Global Top 10 Players Coagulation Factor XI Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Coagulation Factor XI Revenue Share by Type in 2020
Figure 38. Global Coagulation Factor XI Market Share Forecast by Type (2021-2026)
Figure 39. Global Coagulation Factor XI Revenue Share by Application in 2020
Figure 40. Global Coagulation Factor XI Market Share Forecast by Application (2021-2026)
Figure 41. North America Coagulation Factor XI Sales Market Share by Type (2016-2026)
Figure 42. North America Coagulation Factor XI Sales Market Share by Application (2016-2026)
Figure 43. North America Coagulation Factor XI Revenue Market Share by Country (2016-2026)
Figure 44. United States Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Coagulation Factor XI Sales Market Share by Type (2016-2026)
Figure 48. Europe Coagulation Factor XI Sales Market Share by Application (2016-2026)
Figure 49. Europe Coagulation Factor XI Revenue Market Share by Country (2016-2026)
Figure 50. Germany Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Coagulation Factor XI Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Coagulation Factor XI Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Coagulation Factor XI Revenue Market Share by Region (2016-2026)
Figure 58. China Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Coagulation Factor XI Sales Market Share by Type (2016-2026)
Figure 65. South America Coagulation Factor XI Sales Market Share by Application (2016-2026)
Figure 66. South America Coagulation Factor XI Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Coagulation Factor XI Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Coagulation Factor XI Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Coagulation Factor XI Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Coagulation Factor XI Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の凝固因子IX市場 2021：企業別、地域別、種類・用途別 The Coagulation Factor IX market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界の組換え凝固因子市場 2021：企業別、地域別、種類・用途別 The Recombinant Coagulation Factors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のグリア細胞株由来神経栄養因子市場 2021：企業別、地域別、種類・用途別 The Glial Cell Line Derived Neurotrophic Factor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 世界のフォン・ヴィレブランド因子（組換え）市場 2021：企業別、地域別、種類・用途別 The von Willebrand Factor (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のNT3成長因子受容体市場 2021：企業別、地域別、種類・用途別 The NT 3 Growth Factor Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…